Treatment of Patients With Idiopathic Membranous Nephropathy
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Patients with idiopathic membranous nephropathy at risk for renal failure can be identified
in an early stage by measuring urinary low molecular weight proteins and urinary
immunoglobulin G (IgG). This study evaluates the possible benefit of early start of
immunosuppressive therapy in these high-risk patients.